IL79138A - Substituted imidazolidinones,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted imidazolidinones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL79138A
IL79138A IL79138A IL7913886A IL79138A IL 79138 A IL79138 A IL 79138A IL 79138 A IL79138 A IL 79138A IL 7913886 A IL7913886 A IL 7913886A IL 79138 A IL79138 A IL 79138A
Authority
IL
Israel
Prior art keywords
branched
straight
alkyl
optionally substituted
different
Prior art date
Application number
IL79138A
Other languages
English (en)
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of IL79138A publication Critical patent/IL79138A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Cephalosporin Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL79138A 1985-06-21 1986-06-17 Substituted imidazolidinones,their preparation and pharmaceutical compositions containing them IL79138A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21236/85A IT1222367B (it) 1985-06-21 1985-06-21 Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico

Publications (1)

Publication Number Publication Date
IL79138A true IL79138A (en) 1991-04-15

Family

ID=11178826

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79138A IL79138A (en) 1985-06-21 1986-06-17 Substituted imidazolidinones,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US4703054A (no)
EP (1) EP0207680B1 (no)
JP (1) JPH0688979B2 (no)
KR (1) KR870000305A (no)
AT (1) ATE56020T1 (no)
AU (1) AU590283B2 (no)
CA (1) CA1273450A (no)
DE (1) DE3673709D1 (no)
DK (1) DK290386A (no)
FI (1) FI862422A7 (no)
GR (1) GR861578B (no)
HU (1) HUT41741A (no)
IL (1) IL79138A (no)
IT (1) IT1222367B (no)
NO (1) NO166409C (no)
NZ (1) NZ216552A (no)
PH (2) PH23229A (no)
ZA (1) ZA864446B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
JP2606026B2 (ja) * 1991-07-09 1997-04-30 コクヨ株式会社 フォルダー
RU2142470C1 (ru) * 1998-12-22 1999-12-10 Анохина Ирина Петровна Тетрапептид trp-nle-asp-phenh-ch(ch3)2, обладающий антиалкогольной активностью
CA2397644A1 (en) * 2000-01-18 2001-07-26 The Regents Of The University Of California Acid addition salts of imidazolidinones as reaction catalysts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449029A (de) * 1963-08-12 1967-12-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1209644B (it) * 1985-06-21 1989-08-30 Isf Spa Composti farmacologicamente attivi.

Also Published As

Publication number Publication date
FI862422A7 (fi) 1986-12-22
US4703054A (en) 1987-10-27
JPS6230763A (ja) 1987-02-09
IT1222367B (it) 1990-09-05
NO166409C (no) 1991-07-24
GR861578B (en) 1986-10-21
DK290386D0 (da) 1986-06-20
EP0207680A3 (en) 1989-01-18
KR870000305A (ko) 1987-02-17
PH24336A (en) 1990-06-13
AU590283B2 (en) 1989-11-02
FI862422A0 (fi) 1986-06-06
EP0207680A2 (en) 1987-01-07
EP0207680B1 (en) 1990-08-29
CA1273450A (en) 1990-08-28
NO862487L (no) 1986-12-22
NO862487D0 (no) 1986-06-20
DE3673709D1 (de) 1990-10-04
IT8521236A0 (it) 1985-06-21
NO166409B (no) 1991-04-08
PH23229A (en) 1989-06-06
DK290386A (da) 1987-02-11
HUT41741A (en) 1987-05-28
ZA864446B (en) 1987-03-25
JPH0688979B2 (ja) 1994-11-09
NZ216552A (en) 1989-11-28
AU5891786A (en) 1986-12-24
ATE56020T1 (de) 1990-09-15

Similar Documents

Publication Publication Date Title
IL74631A (en) 3-substituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them
AU586259B2 (en) 5-oxo-1-imidazolidine-acetamide derivatives
ZA864446B (en) Imidazolidinones and imidazolidines,process for the preparation and their use
AU587258B2 (en) N-substituted-4-hydroxy-2-oxopyrrolidine derivatives
GR3000215T3 (en) Peptide immunostimulants